2, 4-Dichlorobenzyl Alcohol Market 2021 Share, Trend, Segmentation And Forecast To 2027
The global market for 2, 4-dichlorobenzyl alcohol is witnessing a spurting rise recently, mainly due to the coronavirus outbreak. Rising usages of DCBA substrates in the treatment or prevention of viral infections caused by SARS-associated coronavirus acts as a key driving force for the market growth. Moreover, growth in the rapidly growing end-use industries of DCBA, such as pharmaceutical, agriculture, cosmetics & personal care, and general industries accelerates the market growth.
According to Market Research Future (MRFR), the global 2, 4-dichlorobenzyl
alcohol market is poised to witness significant growth by 2023, registering an
impressive CAGR during the forecast period (2017–2023). Increasing incidences
of chronic disease push the consumption of DCBA in the pharmaceutical industry
to develop breakthrough medicines. Also, advances in active pharmaceutical
ingredients (API) manufacturing technology, alongside the growing urbanization
worldwide, foster the growth of the market.
Request
a Free Sample @ https://www.marketresearchfuture.com/sample_request/4348
Additionally, the increasing usages of DCBA materials in agricultural
activities led by the rising demand for quality crop production are predicted
to drive market growth during the forecast period. Moreover, increasing
awareness among farmers about the benefits of insecticide on crop yield is
estimated to fuel the growth of the market. Also, the massive absorption of
DCBA by the prominent end-use industries would help the market to grow at a
steady pace.
On the other hand, stringent regulation implemented by REACH and EPA to
limit DCBA content in cosmetics & personal care is expected to slightly
hamper the growth of the market, especially in Europe and North American
regions. Nevertheless, the awareness of personal hygiene increasing due to the
COVID 19 pandemic would support the growth of the market, increasing the
consumption of sanitation products.
Global 2, 4-Dichlorobenzyl Alcohol Market
– Competitive Landscape
The DCBA market
appears to be highly competitive due to the presence of several
well-established players. The growth potential demonstrated by the market
attracts several new entrants. The market competition is estimated to fierce
during the anticipated period. Due to the low product differentiation and
similarities, these players aim to develop their DCBA uniquely and minimize
brand recall through effective marketing communications.
Also, to
gain a larger competitive share, players adopt strategic approaches such as
mergers & acquisitions, collaboration, expansion, and technology launch. To
increase their foothold in the market, players offer products at much lower
prices. To extend their geographical reach and maximize their profit shares,
these players focus on increasing their market value.
Major
Players
Players
leading the global DCBA market include Reckitt Benckiser Healthcare
International Ltd. (UK), BASF SE (Germany), Sigma-Aldrich Co. LLC (US), Santa
Cruz Biotechnology, Inc. (US), EMKA-Chemie Gmbh & Co. KG (Germany), Bioxera
Pharma Private Limited (India), and Benzo Chem Industries Pvt. Ltd. (India),
among others.
2, 4-Dichlorobenzyl Alcohol Market
- Segments
The report is segmented into three dynamics;
By
Application : Insecticide,
Preservative, Chemical Intermediate, and others.
By
End Use Industry : Agriculture,
Pharmaceutical, Cosmetics & Personal Care, General Industry, and others.
By Regions : Europe, North America, APAC,
and Rest-of-the-world.
Global 2, 4-Dichlorobenzyl Alcohol Market - Regional Analysis
North
America dominates the global 2, 4-dichlorobenzyl alcohol market. The largest
market share attributes to the strong base for the industrial sector and
increasing applications of DCBA in rapidly growing end-use industries in the
region. Besides, rising investments made in the development of medicines
containing DCBA for the treatment or prevention of viral infections caused by
SARS-associated coronavirus.
The US DCBA
market leads the regional market, heading with the higher penetration of pharma
industries in the country. The North American 2, 4-dichlorobenzyl alcohol
market is expected to witness significant growth over the forecast period.
Europe
stands second in the global 2, 4-dichlorobenzyl alcohol market. The market is
majorly driven by developed end-use industries and rising expenditure on
research and development. Moreover, factors such as innovations in medicines
and increasing per capita healthcare expenditures foster regional market
growth. European countries such as Russia, Germany, France, Italy, and the UK
have emerged as a prominent consumer market for DCBA due to rising usages in
pharmaceutical sectors.
The 2,
4-dichlorobenzyl alcohol market in the Asia Pacific region is emerging as a
promising market. Factors such as the expansion in various end-use industries
such as agriculture and cosmetics & personal care and favorable regulatory
framework for products containing DCBA drive the regional market growth.
Besides, increasing consumer base, rising per capita incomes and the raw
material advantage in the region fosters the regional DCBA market growth. The
APAC DCBA market is estimated to grow at the highest CAGR during the review
period.
Access Report Details @ https://www.marketresearchfuture.com/reports/2-4-dichlorobenzyl-alcohol-market-4348
Industry/
Innovation/ Related News:
February
24, 2020 ---- BMC
Research Notes (the UK), a research organization supporting all scientific and
clinical disciplines, announced that one of its group of scientists presented
findings of the study on Bactericidal activity of hexylresorcinol lozenges to
fight oropharyngeal organisms associated with an acute sore throat. The team
concluded that that hexylresorcinol lozenges offer rapid relief in organisms
implicated in acute sore throat.
In a
similar in vitro study, scientists reported that lozenges containing 0.6 mg
amylmetacresol (AMC) and 1.2 mg 2,4-dichlorobenzyl alcohol show antibacterial
activity against a similar range of oropharyngeal organisms associated with the
acute sore throat. Acute sore throat is a common symptom in an upper
respiratory tract infection (URTI) related to inflammation of the pharynx,
tonsils, or nasopharynx.
The present
invention indicates the use of formulations of DCBA and amylmetacresol in the
treatment or prevention of Severe Acute Respiratory Syndrome (SARS), a viral
respiratory illness caused by a novel coronavirus, termed as SARS-associated
coronavirus (SARS-CoV). The pharmaceutical composition comprising
2,4-dichlorobenzyl alcohol and amylmetacresol can be used in the treatment
& prevention of viral infections caused by SARS-associated coronavirus.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients. Our market research
studies by Components, Application, Logistics and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important
questions.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune 411028
Maharashtra, India
+1 646 845 9312
Email:sales@marketresearchfuture.com
Comments
Post a Comment